Novel neurohumoral factors in congestive heart failure: Adrenomedullin

被引：4

作者：

Lainchbury J.G. ^{[1
]}

机构：

[1] Cardioendocrine Research Group, Christchurch Hospital, Christchurch

来源：

Current Cardiology Reports | 2001年 / 3卷 / 3期

关键词：

Heart Failure; Vascular Smooth Muscle Cell; Brain Natriuretic Peptide; Atrial Natriuretic Peptide; Pulmonary Capillary Wedge Pressure;

D O I：

10.1007/s11886-001-0024-y

中图分类号：

学科分类号：

摘要：

Adrenomedullin is a 52-amino acid peptide that circulates in human plasma. The plasma concentrations of the peptide are increased in cardiovascular disease in proportion to the degree of hemodynamic impairment. Plasma adrenomedullin levels in heart failure, and in subjects with acute myocardial infarction, have been shown to convey independent prognostic information. Adrenomedullin has multiple biologic effects, but characteristically causes vasodilatation. The actions of adrenomedullin and the activation of this peptide in cardiovascular disease suggest it may have an important pathophysiologic role in heart failure. Manipulation of adrenomedullin or its receptor may have therapeutic potential. © 2001 by Current Science Inc.

引用

页码：208 / 214

页数：6

共 86 条

[1]

Kitamura K., Kangawa K., Kawamoto M., Et al., Adrenomedullin: A novel hypotensive peptide isolated from human PC, Biochem Biophys Res Commun, 192, pp. 553-560, (1993)

[2]

Ishiyama Y., Kiramura K., Ichiki Y., Et al., Haemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats, Eur J Pharmacol, 41, pp. 271-273, (1993)

[3]

Jougasaki M., Wei C.-M., Aarhus L.L., Et al., Renal localization and actions of adrenomedullin: A natriuretic peptide, Am J Physiol, 268, (1995)

[4]

Ichiki Y., Kitamura K., Kangawa K., Et al., Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma, FEBS Lett, 338, pp. 6-10, (1994)

[5]

Jougasaki M., Wei C.M., McKinley L.J., Burnett J.C., Elevation of circulating and ventricular adrenomedullin in human congestive heart failure, Circulation, 92, pp. 286-289, (1995)

[6]

Ishimitsu T., Kojima M., Kangawa K., Et al., Genomic structure of human adrenomedullin gene, Biochem Biophys Res Commun, 203, pp. 631-639, (1994)

[7]

Kitamura K., Sakata J., Kangawa K., Et al., Cloning and characterization of cDNA encoding a precursor for human adrenomedullin, Biochem Biophys Res Commun, 194, pp. 720-725, (1993)

[8]

Kitamura K., Kangawa K., Ishiyama Y., Et al., Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP), FEBS Lett, 351, pp. 35-37, (1994)

[9]

Shimosawa T., Ando K., Fujita T., A newly identified peptide, proadrenomedullin N-terminal 20 peptide, induces hypotensive action via pertussis toxin-sensitive mechanisms, Hypertension, 30, pp. 1009-1014, (1997)

[10]

Muff R., Born W., Fischer J.A., Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: Homologous peptides, separate receptors and overlapping biological actions, Euro J Endocrinol, 133, pp. 17-20, (1995)

← 1 2 3 4 5 6 7 8 9 →